Thomas, Mayer & Associés (TMA) advised the biotech firm O&O mdc, an engineering company in ophthalmic medical devices, specialising in Intraoculair Lenses(IOL) and viscoelastic manufacturing, research into new technologies and project development, in the sale of its business to He Vision Group, 何氏眼保健体系, a group of companies specialized in comprehensive eye care system including eye specialists hospital, vision centres, university, research industry centre.
Acquisition of the Anglo-Italian Biotech O&O MDC by the Chinese Group
Cookies are used on this website to improve the user experience and to ensure the efficient functioning of the website.
By using this website, you agree to the use of these cookies please read the Cookies page.
- Recent News: Partner Alexis L. Cirel Admitted to State Bar of Michigan
- Recent News: New York State Announces 2025 Medicaid Income and Asset Levels
- Recent News: Alexis Cirel Featured in Annual "Future of Fertility" Report
- Recent News: Immigration Update - February 2025
- Recent News: U.S. Citizenship and Immigration Services FY 2026 H-1B Cap Registration Period Opens March 7